Sort   by:  
 Page size 
UnknownSWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
Not available
S-EPMC4534524 | biostudies-literature
UnknownMenin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.
Not available
S-EPMC12824668 | biostudies-literature
UnknownLong-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Not available
S-EPMC3515768 | biostudies-literature
UnknownPrediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology.
Not available
S-EPMC11213114 | biostudies-literature
UnknownPlasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials.
Not available
S-EPMC12092243 | biostudies-literature
UnknownMeta-Analysis of Genome-Wide Association Studies Reveals Genetic Mechanisms of Supraventricular Arrhythmias.
Not available
S-EPMC11187659 | biostudies-literature
UnknownRelationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795 | biostudies-literature
UnknownUpregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.
Not available
S-EPMC10020086 | biostudies-literature
UnknownModeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
Not available
S-EPMC4596916 | biostudies-literature
UnknownSocial Determinants of Health and Risk for Long COVID in the U.S. RECOVER-Adult Cohort.
Not available
S-EPMC12352746 | biostudies-literature
Sort   by:  
 Page size